Skip to main content
Advanced Enzyme Technologies Limited logo

Advanced Enzyme Technologies Limited — Investor Relations & Filings

Ticker · ADVENZYMES ISIN · INE837H01020 LEI · 335800PWJRERMBTUUV90 BSE.NS Manufacturing
Open in API
Filings indexed 938 across all filing types
Latest filing 2025-01-06 Regulatory Filings
Country IN India
Listing BSE.NS ADVENZYMES

About Advanced Enzyme Technologies Limited

https://www.advancedenzymes.com/

Advanced Enzyme Technologies Limited is a research-driven company specializing in the development, manufacturing, and marketing of proprietary enzyme products and probiotics. The company operates across the entire enzyme value chain, from research and development to commercial-scale production. Its diverse portfolio serves multiple sectors, including human nutrition, animal nutrition, and industrial processing. Key applications encompass food and beverage production, dietary supplements, animal feed additives, and various industrial processes such as textiles, detergents, and pulp and paper manufacturing. With a focus on biotechnology and sustainable solutions, the firm leverages its extensive R&D capabilities to provide customized enzyme formulations. The company maintains a global footprint, supplying specialized biological solutions to a broad international client base.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about scheduled analyst and institutional investor meetings. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and provides dates and types of meetings. There is no financial data, no detailed presentation, no report attached or referenced beyond the meeting schedule. The document is an announcement of an upcoming investor meeting rather than the meeting materials or transcript itself. Therefore, it fits best under the category of Investor Presentation (IP) as it relates to investor communications and meetings, but since it only announces the meeting schedule and does not contain the presentation itself, it is more appropriate to classify it as Regulatory Filings (RNS) which is the fallback for miscellaneous regulatory announcements that do not fit other categories. Given the short length and nature of the document, confidence is high.
2025-01-06 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about the closure of the trading window due to upcoming financial results announcement for the quarter and nine months ended December 31, 2024. It references the insider trading regulations and the timing of the trading window closure but does not contain any financial data, results, or detailed report content. The document is essentially an announcement related to compliance and trading restrictions ahead of a financial report release. Given its brevity (1170 characters) and nature as an announcement rather than a report, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-12-27 English
General Updates
Capital/Financing Update Classification · 95% confidence The document is a short notification about the completion of an investment in equity shares of a wholly owned subsidiary. It provides details of the transaction but does not contain financial statements, detailed analysis, or comprehensive report content. The document is an update on a financing activity related to capital investment in a subsidiary. Given the nature of the content—an update on a capital transaction—and the document length (1597 characters), it fits best under Capital/Financing Update (CAP).
2024-12-19 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice informing the stock exchanges about a scheduled Analyst / Institutional Investor Meeting. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and provides details about the date and type of meeting. There is no financial data, report content, or detailed presentation included. The document is essentially an announcement of an upcoming investor meeting rather than the meeting materials or transcript itself. Given the short length (1260 characters) and the nature of the content, this fits best under the category of Investor Presentation announcements or meeting notifications. However, since it is only an intimation of the meeting schedule and not the presentation itself, the closest fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory announcements that do not fit other categories.
2024-12-16 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about a scheduled Analyst / Institutional Investor Meeting. It references compliance with SEBI Listing Obligations and Disclosure Requirements but does not contain any financial data, report, or detailed presentation. The document is brief (1577 characters) and serves as an announcement of an upcoming event rather than the event content or financial results. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement rather than a detailed investor presentation or report.
2024-12-13 English
Acquisition
Capital/Financing Update Classification · 95% confidence The document is an intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the formation of a new wholly owned subsidiary and the spin-off of certain assets and liabilities. It provides detailed information about the transaction, including the nature of the acquisition, regulatory approvals, consideration, and background of the new entity. This type of disclosure is typical of a Capital/Financing Update as it relates to corporate restructuring and subsidiary formation, which affects the company's capital structure and business operations. The document is not a full financial report, earnings release, or management discussion, nor is it a regulatory filing of a different nature. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2024-12-05 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.